By Professor Emad El-Omar

Conference Papers

McColl KEL; El-Omar E, 2002, 'How does H. Pylori infection cause gastric cancer?', in Keio Journal of Medicine, pp. 53 - 56, http://dx.doi.org/10.2302/kjm.51.supplement2_53

El-Omar EM, 2002, 'Gene-environment interactions in gastric cancer', in BRITISH JOURNAL OF CANCER, NATURE PUBLISHING GROUP, pp. S8 - S8

Atherton J; Aviles-Jimenez F; Blaser MJ; McColl KEL; Fraumeni JF; Rabkin CS; El-Omar EM, 2002, 'Host interleukin-1 and H-pylori vacA genotypes are independent risk factors for hypochlorhydria and atrophy in gastric cancer relatives', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A170 - A170

Finlayson NDC; Tomlinson S; Weetman AP; Connell JMC; Hill AVS; Savage CO; Wiles CM; Williams B; Ireland J; Vallance P; Whyte M; Seckl JR; Jung R; McKillop JH; Stout RW; Atkinson AB; Tomkin GH; Adgey AAJ; Axon ATR; Beck P; Eastwood JB; Fitzgerald M; Godman MJ; Heath DA; Kendall MJ; MacGregor GA; Petrie JC; Ell RGG; Allan RN; Barry RE; Boulton Jones JM; Evans CC; George CF; Heading RC; Jewell DP; Lazarus JH; Parker AC; Rawlins MD; Thurston H; Cappuccio FP; Conlon CP; John CS; Dornhurst A; Douglas JG; Elborn JS; El-Omar E; Friedland JS; Gilks CF; Groves RW; Hall AS; Hawkey CJ; Hillhouse E; Hughes J; Isaacs J; Jardine AG; Jodrell DI; Jones DEJ; Monson JP; Price P; Pugh CW; Ray DW; Santis G; Satsangi J; Scott DGI; Scott DL; Vickers MA; Wardlaw A, 2001, 'The ninety-fifth annual general meeting of the association of physicians of Great Britain and Ireland 2001', in QJM an International Journal of Medicine, pp. 643 - 655

El-Omar EM; You WC; Chow WH; Fraumeni JF; Rabkin CS, 2001, 'IL-1beta and IL-10 genotypes in a high gastric cancer risk province in China', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A743 - A743, http://dx.doi.org/10.1016/S0016-5085(01)83701-X

El-Omar EM; Chow WH; Gammon MD; Vaughan TL; Risch HA; Fraumeni JF, 2001, 'Pro-inflammatory genotypes of IL-1β, TNF-α and IL-10 increase risk of distal gastric cancer but not of cardia or oesophageal adenocarcinomas', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A86 - A86, http://dx.doi.org/10.1016/S0016-5085(01)80425-X

McColl KEL; El-Omar E, 2000, 'Mechanisms involved in the development of hypochlorhydria and pangastritis in Helicobacter pylori infection', in Hunt RH; Tytgat GNJ (ed.), HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, SPRINGER, BERMUDA, pp. 373 - 384, presented at 4th Symposium on Helicobacter Pylori - Basic Mechanisms to Clinical Cure, BERMUDA, 26 March 2000 - 29 March 2000, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000167245700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

El-Omar EM; McColl KEL; Perez-Perez GI; Olivares-Perez A; Blaser MJ, 1999, 'H pylori genotypes and clinical and histopathological findings in first degree relatives of patients with non-cardia gastric adenocarcinoma', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A154 - A154

McColl KEL; Dickson A; El-Nujumi AM; El-Omar EM; Kelman A, 1999, 'Symptomatic benefit 1-3 years post H-pylori eradication in ulcer patients:: Impact of reflux disease.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A249 - A249

El-Omar EM; Thompson SA; Blaser MJ, 1998, 'Ablation of fucosyl transferase homologs has varying effects on H-pylori Lewis antigen expression.', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A972 - A972, http://dx.doi.org/10.1016/S0016-5085(98)83958-9

El-Omar EM; Oien K; El-Nujumi A; Wirz A; Gillen D; Williams C; Ardill JES; Fullarton G; McColl KEL, 1998, 'H-pylori induced hypochlorhydria and gastric atrophy associated with increased gastric cancer risk', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. 1A - 1A

ElOmar E; Oien K; ElNujumi A; Gillen D; Wirz A; Fullarton G; Penny C; McColl KEL, 1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A558 - A558

ElOmar E; Oien K; ElNujumi A; Gillen D; Wirz A; Fullarton G; Penny C; McColl KEL, 1997, 'H-pylori induced hypochlorhydria is associated with increased risk of gastric cancer.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. WA32 - WA32

Oien K; ElOmar EM; Dahill S; ElNujumi A; Gillen D; Wirz A; Williams C; Ardill JES; McColl KEL, 1997, 'H-pylori infection and gastric acid hyposecretion', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A30 - A30

McColl KEL; ElOmar E; Gillen D; Ardill JES; Murray L; Crabtree JE, 1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215

McColl KEL; ElOmar E; Gillen D; Ardill JES; Murray L; Crabtree JE, 1997, 'H-pylori-induced hypergastrinaemia is related to bacterial CagA status.', in GUT, BMJ PUBLISHING GROUP, pp. TH183 - TH183

Hassen S; Vollset SE; Ardill JES; ElOmar E; Melby K; Aase S; Jellum E; McColl KEL, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A45 - A45

Hansen S; Vollset SE; Ardill JES; ElOmar E; Melby K; Aase S; Jellum E; McColl KEL, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. A1 - A1

Hansen S; Vollset SE; Ardill JES; ElOmar E; Melby K; Aase S; Jellum E; McColl KEL, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A575 - A575

Hansen S; Vollset SE; Ardill JES; ElOmar E; Melby K; Aase S; Jellum E; McColl KEL, 1997, 'Hypergastrinaemia is a strong predictor of distal gastric adenocarcinoma among Helicobacter pylori infected persons.', in GUT, BMJ PUBLISHING GROUP, pp. TH184 - TH184

Penman ID; ElOmar E; Rehfeld JF; McColl KEL, 1997, 'Plasma glycine-extended gastrin concentrations and human colorectal cancer.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A638 - A638

Smith A; Gillen D; Cochran K; ElOmar E; McColl KEL, 1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A293 - A293

Smith A; Gillen D; Cochran K; ElOmar E; McColl KEL, 1997, 'Ranitidine treatment induces dyspepsia in previously asymptomatic healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W11 - W11

Gillen D; ElOmar E; Wirz A; Ardill JES; McColl KEL, 1997, 'Regulation of corpus mucosal function in Hp infected DU patients versus healthy volunteers.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A126 - A126

Gillen D; ElOmar E; Wirz A; Ardill JES; McColl KEL, 1997, 'Regulation of corpus mucosal function in HP infected DU patients versus healthy volunteers.', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. W12 - W12

McColl KEL; ElNujumi A; Murray L; ElOmar E, 1997, 'Variable symptomatic response to H-pylori eradication in ulcer patients.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A215 - A215

McColl KEL; El-Omar E, 1996, 'Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer', in Scandinavian Journal of Gastroenterology Supplement, pp. 32 - 37

ElOmar E; Olen K; Wirz K; Wirz A; McColl KEL, 1996, 'Divergent effects of H-pylori on acid secretion.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A102 - A102

McColl KEL; ElNujumi A; ElOmar E; Dickson A, 1996, 'Evidence supporting a H-pylori test and treat strategy for simple dyspepsia.', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A28 - A28

Gillen D; ElOmar E; McColl KEL, 1996, 'Parietal cell sensitivity to gastrin distinguishes H-pylori infected DU patients from infected healthy volunteers', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, pp. A116 - A116

PENMAN ID; ARDILL JES; ELOMAR E; MCKENZIE J; MCCOLL KEL, 1995, 'GASTRIN AND ITS PRECURSORS IN HUMAN COLORECTAL-CANCER', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A524 - A524

ELOMAR E; PENMAN ID; ARDILL JES; MCCOLL KEL, 1994, 'A SUBSTANTIAL PROPORTION OF NUD PATIENTS HAVE THE SAME ABNORMALITY OF ACID-SECRETION AS DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74

PENMAN ID; ELOMAR E; MCGREGOR JR; ARDILL JES; GALLOWAY D; ODWYER PJ; MCCOLL KEL, 1994, 'FASTING AND MEAL-STIMULATED GASTRIN-LEVELS PREOPERATIVELY AND POSTOPERATIVELY IN COLORECTAL TUMOR PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A428 - A428

ELOMAR E; BANERJEE S; PENMAN ID; ARDILL JES; MCCOLL KEL, 1994, 'HELICOBACTER-PYLORI IMPAIRS THE INHIBITORY CONTROL OF ACID-SECRETION IN DUODENAL-ULCER PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74

ELOMAR E; BANERJEE S; WIRZ A; PENMAN I; ARDILL JES; MCCOLL KEL, 1994, 'MARKED REBOUND ACID HYPERSECRETION IN HEALTHY-VOLUNTEERS FOLLOWING RANITIDINE', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A74 - A74

BANERJEE S; ELOMAR E; MOWAT A; ARDILL JES; PARK RHR; WATSON W; BEATTIE AD; MCCOLL KEL, 1994, 'SUCRALFATE SUPPRESSES HELICOBACTER-PYLORI INFECTION AND REDUCES GASTRIC-ACID SECRETION BY 50-PERCENT IN DU PATIENTS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A45 - A45

ELOMAR E; PENMAN I; DORRIAN CA; ARDILL JES; MCCOLL KEL, 1993, 'ERADICATING HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS AND BY 50-PERCENT IN HEALTHY-VOLUNTEERS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A75 - A75

PENMAN ID; ELOMAR E; MCGREGOR JR; HILLAN KJ; ODWYER P; MCCOLL KEL, 1993, 'OMEPRAZOLE INHIBITS AZOXYMETHANE-INDUCED COLORECTAL CARCINOGENESIS IN RATS', in GASTROENTEROLOGY, W B SAUNDERS CO, pp. A441 - A441

ELOMAR E; BOYD EJS; PENMAN I; MCCOLL KEL, 1992, 'ERADICATION OF HELICOBACTER-PYLORI INFECTION DURING LONG-TERM SULFASALAZINE THERAPY', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28

ELOMAR E; PENMAN I; DORRIAN CA; ARDILL JES; MCCOLL KEL, 1992, 'ERADICATION OF HELICOBACTER-PYLORI LOWERS GASTRIN-MEDIATED ACID-SECRETION BY 70-PERCENT IN DU PATIENTS', in GUT, BRITISH MED JOURNAL PUBL GROUP, pp. S28 - S28

ANTHONY R; ELOMAR E; MACSWEEN RNM; WHALEY K, 1987, 'SEPARATE SIGNALS ARE REQUIRED FOR THE STIMULATION OF HEPATIC SYNTHESIS OF THE 3RD AND 4TH COMPONENTS OF COMPLEMENT DURING THE ACUTE-PHASE RESPONSE', in JOURNAL OF PATHOLOGY, JOHN WILEY & SONS LTD, pp. A68 - A68

MCCOLL KEL; ELOMAR E; MACPHEE GJA; THOMPSON GG; MOORE MR; PARK BK; BRODIE MJ, 1986, 'EFFECTS OF RIFAMPICIN ON HEME-BIOSYNTHESIS AND HEPATIC MONOOXYGENASE ACTIVITY IN HEALTHY-SUBJECTS', in BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, BLACKWELL SCIENCE LTD, pp. P602 - P602

MCCOLL KEL; THOMPSON GG; BIRNIE G; ELOMAR E; MOORE MR; GOLDBERG A, 1985, 'NEW OBSERVATIONS IN GILBERTS SYNDROME', in SCOTTISH MEDICAL JOURNAL, HERMISTON PUBLICATIONS LTD, pp. 56 - 57

Conference Posters

Zhang N; Wang Z; Lv J; Liu Y; Liu T; Zhang S; Li W; Gong L; Zhang X; El-Omar E; Lu W, 2022, 'Characterization of gut microbiota and exploration of potential predictive model for hepatocellular carcinoma microvascular invasion', ENGLAND, London, Vol. 77, pp. S920 - S921, presented at International Liver Congress, ENGLAND, London, 22 June 2022 - 26 June 2022, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826275104366&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Strout N; Pasic L; Hicks C; Chua X-Y; Tashvighi N; Samaras K; Craig M; Davis G; Henry A; Ledger W; El-Omar E, 2022, 'The MothersBabies Study: analysing the preconception microbiome to determine risk of adverse maternal-child health outcomes', presented at Brighter Beginnings First 2000 Days Summit, NSW Ministry of Health, 31 October 2022 - 01 November 2022, https://willorganise.eventsair.com/bb-first-2000-days-summit/day-2

Conference Abstracts

Chacon-Fajardo D; Porazinski S; Man J; Yim H; El-Omar E; Joshua A; Pajic M, 2023, 'Re-purposing non-oncology agent itraconazole to target the dynamic cellular ecosystem of pancreatic cancer', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-A029

Porazinski S; Man J; Chacon-Fajardo D; Yim H; El-Omar E; Joshua A; Pajic M, 2023, 'The anti-fungal itraconazole improves immunotherapy efficacy in pancreatic ductal adenocarcinoma by reversing the immune-suppressive tumor microenvironment', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, MA, Boston, Vol. 84, presented at AACR Special Conference - Pancreatic Cancer, MA, Boston, 27 September 2023 - 30 September 2023, http://dx.doi.org/10.1158/1538-7445.PANCA2023-C017

Shen SS; Jackson M; Khatiwada S; Vijayan A; Raposo A; El-Omar E; Behary J; Zekry A, 2022, 'EFFECT OF GUT INFLUENCE ON THE IMMUNE ENVIRONMENT IN PRE-CLINICAL HCC', in GUT, BMJ PUBLISHING GROUP, Vol. 71, pp. A5 - A5, http://dx.doi.org/10.1136/gutjnl-2022-IDDF.6

Shen SS; Jackson M; Khatiwada S; Raposo A; Vijayan A; El-Omar E; Behary J; Zekry A, 2022, 'Effect of gut influence on the immune environment in preclinical hepatocellular carcinoma', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY, Vol. 37, pp. 38 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000852585700071&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhu W; Zhang N; Wang Z; Zhang S; Yue X; Sun L; Sun J; Gong L; El-Omar EM; Lu W, 2022, 'Characterization analysis of gut and bile microbiota for cholangiocarcinomas.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. e16150 - e16150, http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e16150

Back to profile page